Responding to the challenge, eConsult’s first step was to identify more about what clinicians needed to ease time pressures. Opencast’s developer and QA capabilities helped eConsult to define user needs and understand the competition through market and user research. The immediate aim on that back of that was to create a minimum viable product (MVP) for the new AI tool.
Once through discovery, Opencast developer expertise moved to design and build the new tool, using lean Agile processes. Prototyping and spiking technology, which explores potential solutions, helped the team identify viable and cost-effective solutions that could be integrated into the platform.
Constant iteration and feedback loops informed next steps, consulting on and defining which features the new tool really needed and which were ‘nice to have’. What was definitely essential throughout was the need to devise a product that would be secure and compliant with government regulations and NHS data and information standards, work seamlessly with other NHS technology – and be competitive in a fast-growing marketplace.
With a small team in place, Opencast’s approach to the project was characterised by pragmatism throughout, with QA and developer roles closely intertwined and the team staying flexible enough to take on tasks across both disciplines.
The team modernised testing practices, with a strategy that allowed the team to find and resolve issues faster, improving overall efficiency and the robustness of the eventual Hi Scribe solution.
A key aim of the project was balancing the use of AI to deliver core functionality at the same time as ensuring data protection for patients.
The Opencast QA on the project integrated advanced AI and machine learning services for functionality. To maintain data privacy and compliance, AWS Comprehend was deployed for natural language processing, importantly including its function for identifying and redacting personally identifiable data.
Moving fast, in the first four months of 2025, the team was able take the eConsult concept to private beta then into a potentially saleable product in public beta.
In May 2025, Huma, the global healthcare AI company that had acquired eConsult only seven months earlier to accelerate its drive for digital-first healthcare, publicly announced the launch of Hi Scribe.
The new Hi Scribe product is built on top of Google’s Vertex AI platform, which Huma uses for its Huma AI foundation engine to power the company’s other AI-first tools and products. It leverages Huma’s strategic partnership with Google Cloud to deliver secure, scalable and clinically compliant AI services to healthcare workers.
Data is the fuel for the Hi Scribe product – and it is powered by insights from over 60 million consultations conducted by eConsult.
The new Hi Scribe tool transcribes patient-clinician consultations in real time and automatically generates structured clinical notes for direct integration into NHS and other electronic health record (EHR) systems. This integration enables clinicians to submit documentation seamlessly without disrupting workflows.
The Hi Scribe technology features writeback and coding capabilities for EMIS Health and UK clinical information system SystmOne TPP. And it uses the SNOMED clinical vocabulary, which helps sets Hi Scribe apart from other AI products.
Compliance is at the core of the new tool. It complies with April 2025 NHS England guidance on the use of AI-enabled ambient scribing products in health and care settings, and with regulations set by the UK Medicines and Healthcare products Regulatory Agency (MHRA) as a medical device.